414 related articles for article (PubMed ID: 12514710)
1. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
Bhardwaj N; Walker BD
Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
[No Abstract] [Full Text] [Related]
2. Therapeutic dendritic-cell vaccine for simian AIDS.
Lu W; Wu X; Lu Y; Guo W; Andrieu JM
Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
[TBL] [Abstract][Full Text] [Related]
3. AIDS vaccine models: challenging challenge viruses.
Feinberg MB; Moore JP
Nat Med; 2002 Mar; 8(3):207-10. PubMed ID: 11875482
[No Abstract] [Full Text] [Related]
4. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
[TBL] [Abstract][Full Text] [Related]
5. Preventing AIDS but not HIV-1 infection with a DNA vaccine.
Shen X; Siliciano RF
Science; 2000 Oct; 290(5491):463-5. PubMed ID: 11183769
[TBL] [Abstract][Full Text] [Related]
6. 25 years of HIV research! ... and what about a vaccine?
Appay V
Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
[TBL] [Abstract][Full Text] [Related]
7. Vaccines. Monkey puzzles.
Cohen J
Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
[No Abstract] [Full Text] [Related]
8. Therapeutic AIDS vaccine looks promising.
Expert Rev Vaccines; 2003 Feb; 2(1):5. PubMed ID: 12901591
[No Abstract] [Full Text] [Related]
9. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of virus-specific T cell responses by dendritic cell vaccination in the chronic phase of simian AIDS models.
Kato M; Igarashi H; Takeda A; Horie S; Higashihara E; Matano T
Jpn J Infect Dis; 2004 Oct; 57(5):220-3. PubMed ID: 15507782
[TBL] [Abstract][Full Text] [Related]
11. AIDS vaccines show promise in primates.
Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
[No Abstract] [Full Text] [Related]
12. Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model.
Nehete PN; Nehete BP; Manuri P; Hill L; Palmer JL; Sastry KJ
Vaccine; 2005 Mar; 23(17-18):2154-9. PubMed ID: 15755586
[TBL] [Abstract][Full Text] [Related]
13. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.
Xu R; Srivastava IK; Kuller L; Zarkikh I; Kraft Z; Fagrouch Z; Letvin NL; Heeney JL; Barnett SW; Stamatatos L
Virology; 2006 Jun; 349(2):276-89. PubMed ID: 16527321
[TBL] [Abstract][Full Text] [Related]
14. Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.
Lifson JD; Haigwood NL
Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007310. PubMed ID: 22675663
[TBL] [Abstract][Full Text] [Related]
15. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.
Andrieu JM; Lu W
J Intern Med; 2007 Feb; 261(2):123-31. PubMed ID: 17241177
[TBL] [Abstract][Full Text] [Related]
16. Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles.
Puaux AL; Marsac D; Prost S; Singh MK; Earl P; Moss B; Le Grand R; Riviere Y; Michel ML
Vaccine; 2004 Sep; 22(27-28):3535-45. PubMed ID: 15315833
[TBL] [Abstract][Full Text] [Related]
17. AIDS vaccine development in primate models.
Almond NM; Heeney JL
AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
[No Abstract] [Full Text] [Related]
18. Paradigm change in immune correlation: cellular or humoral?
Matsuo K; Yamamoto N
Expert Rev Vaccines; 2010 Sep; 9(9):985-7. PubMed ID: 20822339
[No Abstract] [Full Text] [Related]
19. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
Yang OO
Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
[No Abstract] [Full Text] [Related]
20. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y
J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
